
    
      This is a prospective, multi-center, randomized controlled trial. The study will be conducted
      in 11 transplant centers in the United States and Canada. Estimated final sample size of 140.
      Pediatric adolescent and young adult (age at enrollment â‰¥12 and < 18) transplant recipients
      will be eligible for participation in the study. Eligible participants will be randomly
      assigned to intervention or control group. An interim analysis to evaluate efficacy will be
      performed. Missing data will not be imputed for secondary analyses.
    
  